EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

Update Il y a 4 ans
Reference: NCT01509144

Woman Man

Extract

Objectives: - To assess the safety of three priming immunisations by nasal route followed by two booster immunisations by intramuscular route - To assess immunogenicity responses induced by the vaccine.


Inclusion criteria

  • HIV

Links